Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?

Saved in:
Bibliographic Details
Published in:Journal of oncology pharmacy practice 2019-12, Vol.25 (8), p.2062-2063
Main Authors: Ürün, Yüksel, Yaşar, H Arzu, Turna, Hande, Kılıçkap, Saadettin, Sezer, Ahmet, Öksüzoğlu, Berna, Özdemir, Nuriye, Şendur, MA Nahit, Abalı, Hüseyin
Format: Article
Language:English
Subjects:
Combined Modality Therapy
Humans
Immunotherapy
Ipilimumab
Melanoma
Prognosis
Radiation therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c318t-840c83c712fa0c3d856be74011a858584fb596f2853fc9df30cad943787384823
container_end_page 2063
container_issue 8
container_start_page 2062
container_title Journal of oncology pharmacy practice
container_volume 25
creator Ürün, Yüksel
Yaşar, H Arzu
Turna, Hande
Kılıçkap, Saadettin
Sezer, Ahmet
Öksüzoğlu, Berna
Özdemir, Nuriye
Şendur, MA Nahit
Abalı, Hüseyin
description
doi_str_mv 10.1177/1078155219858176
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2245605624</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1078155219858176</sage_id><sourcerecordid>2312487111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c318t-840c83c712fa0c3d856be74011a858584fb596f2853fc9df30cad943787384823</originalsourceid><addsrcrecordid>eNp1kEtLAzEUhYMotlb3rmTAjZvR3DwmGTdF6hMqgii4G9KZpKZ0JjWZWfTfm9pWoeAqIec7594chE4BXwIIcQVYSOCcQC65BJHtoT4wIVKck4_9eI9yutJ76CiEGcZYCiIPUY8CIVkOoo-eX_V1MnL1xDaqta5JnEm8qqxrP7VXi2Wimiqxdd0125dhcuuS1ta2mf6IlQs6qVXbaj88RgdGzYM-2ZwD9H5_9zZ6TMcvD0-jm3FaUpBtKhkuJS0FEKNwSSvJs4kWDAOo-A8umZnwPDNEcmrKvDIUl6rKGRVSUMkkoQN0sc5dePfV6dAWtQ2lns9Vo10XCkIYzzDPCIvo-Q46c51v4nYFiTUwKQAgUnhNld6F4LUpFt7Wyi8LwMWq6mK36mg52wR3k1pXv4ZttxFI10BQU_039d_Ab3wBg3g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2312487111</pqid></control><display><type>article</type><title>Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?</title><source>SAGE</source><creator>Ürün, Yüksel ; Yaşar, H Arzu ; Turna, Hande ; Kılıçkap, Saadettin ; Sezer, Ahmet ; Öksüzoğlu, Berna ; Özdemir, Nuriye ; Şendur, MA Nahit ; Abalı, Hüseyin</creator><creatorcontrib>Ürün, Yüksel ; Yaşar, H Arzu ; Turna, Hande ; Kılıçkap, Saadettin ; Sezer, Ahmet ; Öksüzoğlu, Berna ; Özdemir, Nuriye ; Şendur, MA Nahit ; Abalı, Hüseyin</creatorcontrib><identifier>ISSN: 1078-1552</identifier><identifier>EISSN: 1477-092X</identifier><identifier>DOI: 10.1177/1078155219858176</identifier><identifier>PMID: 31226917</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Combined Modality Therapy ; Humans ; Immunotherapy ; Ipilimumab ; Melanoma ; Prognosis ; Radiation therapy</subject><ispartof>Journal of oncology pharmacy practice, 2019-12, Vol.25 (8), p.2062-2063</ispartof><rights>The Author(s) 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c318t-840c83c712fa0c3d856be74011a858584fb596f2853fc9df30cad943787384823</cites><orcidid>0000-0002-9152-9887 ; 0000-0002-0545-1383</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31226917$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ürün, Yüksel</creatorcontrib><creatorcontrib>Yaşar, H Arzu</creatorcontrib><creatorcontrib>Turna, Hande</creatorcontrib><creatorcontrib>Kılıçkap, Saadettin</creatorcontrib><creatorcontrib>Sezer, Ahmet</creatorcontrib><creatorcontrib>Öksüzoğlu, Berna</creatorcontrib><creatorcontrib>Özdemir, Nuriye</creatorcontrib><creatorcontrib>Şendur, MA Nahit</creatorcontrib><creatorcontrib>Abalı, Hüseyin</creatorcontrib><title>Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?</title><title>Journal of oncology pharmacy practice</title><addtitle>J Oncol Pharm Pract</addtitle><subject>Combined Modality Therapy</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Ipilimumab</subject><subject>Melanoma</subject><subject>Prognosis</subject><subject>Radiation therapy</subject><issn>1078-1552</issn><issn>1477-092X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kEtLAzEUhYMotlb3rmTAjZvR3DwmGTdF6hMqgii4G9KZpKZ0JjWZWfTfm9pWoeAqIec7594chE4BXwIIcQVYSOCcQC65BJHtoT4wIVKck4_9eI9yutJ76CiEGcZYCiIPUY8CIVkOoo-eX_V1MnL1xDaqta5JnEm8qqxrP7VXi2Wimiqxdd0125dhcuuS1ta2mf6IlQs6qVXbaj88RgdGzYM-2ZwD9H5_9zZ6TMcvD0-jm3FaUpBtKhkuJS0FEKNwSSvJs4kWDAOo-A8umZnwPDNEcmrKvDIUl6rKGRVSUMkkoQN0sc5dePfV6dAWtQ2lns9Vo10XCkIYzzDPCIvo-Q46c51v4nYFiTUwKQAgUnhNld6F4LUpFt7Wyi8LwMWq6mK36mg52wR3k1pXv4ZttxFI10BQU_039d_Ab3wBg3g</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Ürün, Yüksel</creator><creator>Yaşar, H Arzu</creator><creator>Turna, Hande</creator><creator>Kılıçkap, Saadettin</creator><creator>Sezer, Ahmet</creator><creator>Öksüzoğlu, Berna</creator><creator>Özdemir, Nuriye</creator><creator>Şendur, MA Nahit</creator><creator>Abalı, Hüseyin</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9152-9887</orcidid><orcidid>https://orcid.org/0000-0002-0545-1383</orcidid></search><sort><creationdate>201912</creationdate><title>Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?</title><author>Ürün, Yüksel ; Yaşar, H Arzu ; Turna, Hande ; Kılıçkap, Saadettin ; Sezer, Ahmet ; Öksüzoğlu, Berna ; Özdemir, Nuriye ; Şendur, MA Nahit ; Abalı, Hüseyin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c318t-840c83c712fa0c3d856be74011a858584fb596f2853fc9df30cad943787384823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Combined Modality Therapy</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Ipilimumab</topic><topic>Melanoma</topic><topic>Prognosis</topic><topic>Radiation therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ürün, Yüksel</creatorcontrib><creatorcontrib>Yaşar, H Arzu</creatorcontrib><creatorcontrib>Turna, Hande</creatorcontrib><creatorcontrib>Kılıçkap, Saadettin</creatorcontrib><creatorcontrib>Sezer, Ahmet</creatorcontrib><creatorcontrib>Öksüzoğlu, Berna</creatorcontrib><creatorcontrib>Özdemir, Nuriye</creatorcontrib><creatorcontrib>Şendur, MA Nahit</creatorcontrib><creatorcontrib>Abalı, Hüseyin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of oncology pharmacy practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ürün, Yüksel</au><au>Yaşar, H Arzu</au><au>Turna, Hande</au><au>Kılıçkap, Saadettin</au><au>Sezer, Ahmet</au><au>Öksüzoğlu, Berna</au><au>Özdemir, Nuriye</au><au>Şendur, MA Nahit</au><au>Abalı, Hüseyin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?</atitle><jtitle>Journal of oncology pharmacy practice</jtitle><addtitle>J Oncol Pharm Pract</addtitle><date>2019-12</date><risdate>2019</risdate><volume>25</volume><issue>8</issue><spage>2062</spage><epage>2063</epage><pages>2062-2063</pages><issn>1078-1552</issn><eissn>1477-092X</eissn><cop>London, England</cop><pub>SAGE Publications</pub><pmid>31226917</pmid><doi>10.1177/1078155219858176</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-9152-9887</orcidid><orcidid>https://orcid.org/0000-0002-0545-1383</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1078-1552
ispartof Journal of oncology pharmacy practice, 2019-12, Vol.25 (8), p.2062-2063
issn 1078-1552
1477-092X
language eng
recordid cdi_proquest_miscellaneous_2245605624
source SAGE
subjects Combined Modality Therapy
Humans
Immunotherapy
Ipilimumab
Melanoma
Prognosis
Radiation therapy
title Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T07%3A16%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Re:%20Combination%20of%20radiotherapy%20and%20immunotherapy?%20Do%20timing%20and%20dose%20matter?&rft.jtitle=Journal%20of%20oncology%20pharmacy%20practice&rft.au=%C3%9Cr%C3%BCn,%20Y%C3%BCksel&rft.date=2019-12&rft.volume=25&rft.issue=8&rft.spage=2062&rft.epage=2063&rft.pages=2062-2063&rft.issn=1078-1552&rft.eissn=1477-092X&rft_id=info:doi/10.1177/1078155219858176&rft_dat=%3Cproquest_cross%3E2312487111%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c318t-840c83c712fa0c3d856be74011a858584fb596f2853fc9df30cad943787384823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2312487111&rft_id=info:pmid/31226917&rft_sage_id=10.1177_1078155219858176&rfr_iscdi=true